Loading...

UroGen Pharma Ltd.

URGN•NASDAQ
Healthcare
Biotechnology
$18.95
$0.95(5.28%)

UroGen Pharma Ltd. (URGN) Stock Chart & Performance Analysis

Explore UroGen Pharma Ltd.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-7.03%
5-Day Change
-8.75%
1-Month Change
-5.34%
3-Month Change
-8.30%
6-Month Change
-21.16%
Year-to-Date (YTD) Change
-12.24%
1-Year Change
-27.49%
3-Year Change
18.86%
5-Year Change
-60.40%
All-Time (Max) Change
-32.83%

Analyzing UroGen Pharma Ltd. (URGN) Trends Across Multiple Time Frames

UroGen Pharma Ltd. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. UroGen Pharma Ltd. stock shows -7.03% 1-day change, indicating low volatility, while its 5-day change of -8.75% suggests a broader trend. Over a 1-month period, a -5.34% drop could signal a pullback, whereas a 3-month decline of -8.30% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -21.16% and a YTD drop of -12.24% might concern investors, but a 1-year loss of -27.49% and a 3-year increase of 18.86% could indicate resilience. The 5-year surge of -60.40% highlights weak historical growth, while the all-time return of -32.83% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;